To review evidence evaluating the use of multicomponent frailty assessment tools in assessing frailty in older adults with psychiatric disorders. METHODS: A systematic literature review was conducted to identify all multicomponent frailty assessment tools (ie, a tool that assesses two or more indicators of frailty). The items of each frailty assessment tool were compared with Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) diagnostic criteria for psychiatric disorders to assess construct overlap. Studies conducted in community, inpatient, and outpatient clinical settings were considered for inclusion. PARTICIPANTS: Adults aged 60 years or older. RESULTS: A total of 5639 records were identified following the removal of duplicates, from which 95 studies were included for review. Of the 48 multicomponent frailty assessment tools identified, no tool had been developed for, or validated in, older adult populations with a psychiatric disorder. Overall, 20 of 48 frailty assessment tools contained a psychological assessment domain, with 17 of 48 tools citing the presence of depressed mood and/or anxiety as a frailty indicator. Common areas of construct overlap in frailty assessment tools and DSM-5 diagnostic criteria included weight loss (29 of 48) and fatigue (21 of 48). CONCLUSIONS: Significant construct overlap exists between the indicators of frailty as conceptualized in existing frailty assessment tools and DSM-5 diagnostic criteria for common psychiatric disorders including major depressive episode and generalized anxiety disorder that has the potential to confound frailty assessment results. Further research is necessary to establish a reliable and valid tool to assess frailty in this population.
F
railty is a prevalent issue in later life, with evidenced links to adverse outcomes including functional decline, falls, institutionalization, and mortality. [1] [2] [3] [4] [5] Frailty is a multifactorial clinical state or syndrome; it represents decline in multiple physiologic systems resulting in poor maintenance of homeostasis and decreased reserves and resilience to stressors. 6, 7 A number of models have conceptualized frailty. The two most widely accepted are the Canadian Study of Health and Aging Cumulative Deficit Model 8 and the Cardiovascular Health Study Phenotype Model. 9 The cumulative deficit model assesses frailty through an index of deficits associated with aging including disabilities and diseases; a higher index score indicates a higher level of frailty, with no cut point to distinguish between frail and robust. 8 The phenotype model establishes a frailty phenotype consisting of these frailty indicators: involuntary weight loss, self-reported exhaustion, self-reported sedentary behavior, slow gait speed, and weak grip strength. 9 The presence of zero frailty indicators suggests an individual is robust, one to two frailty indicators is suggestive of pre-frailty (the intermediate stage between robust and frail), and three or more indicators confirm frailty. 9 Frailty and psychiatric disorders, such as major depressive disorder (MDD) and generalized anxiety disorder (GAD), are thought to be distinct but highly related clinical entities. 10, 11 Evidence suggests that frailty and psychiatric disorders are highly comorbid. 11, 12 A systematic review of evidence exploring comorbidity of frailty and depression found that 4% to 16% of frail adults aged 60 years or older had major depression, with this number rising to 35% in frail older adults aged 75 years or older and in male populations. 12 The rate of comorbid frailty in depressed older adult populations reached 46% to 57%. 12 In addition to comorbidity, good evidence supports a bidirectional association between depression/anxiety and frailty in later life. 11, [13] [14] [15] Evidence suggests that older adults with a psychiatric disorder are at an increased risk of becoming frail and often experience the highest levels of frailty. 16, 17 For example, a cross-sectional observational study by Collard and colleagues 18 found that the overall prevalence of physical frailty in a depressed older adult population was 27.0%, three times higher than the prevalence in the study's nondepressed sample (9.1%). Conversely, evidence suggests that frailty is associated with an increased chance of developing clinically meaningful depression and anxiety symptoms. 11, [13] [14] [15] Furthermore, physical frailty was shown to adversely affect the course of late-life depression, with increased odds of nonremission associated with increased physical frailty. 19 Brown and colleagues 20 proposed a depressed frail phenotype as a high-risk profile for late-life frailty. Given that psychiatric disorders are also pervasive late-life issues with increased risks for many of the same adverse outcomes as frailty including dementia and morality, 21, 22 frailty in the context of a psychiatric disorder warrants specialist clinical detection and intervention.
Frailty is widely considered to be a dynamic process with potential for restorative and preventive clinical interventions. 6, 23 The need to develop new treatment modalities to address frailty in the context of psychiatric disorders was recently highlighted. 12, 19 The accurate assessment of frailty is key in the development and provision of such interventions. A 2016 systematic review of the psychometric properties of existing multicomponent frailty assessment tools found the extent and quality of psychometric testing of these tools to be limited. 24 Only 2 of the 38 tools included for review evidenced reliability and validity data within statistically significant parameters and were of fair to excellent quality according to the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) checklist, 25 the Frailty Index-Comprehensive Geriatric Assessment (FI-CGA) 26 and the Tilburg Frailty Indicator (TFI). 27 To date, no frailty assessment tool has been widely accepted as a gold standard. 24 Given the high comorbidity of frailty and psychiatric disorders in late life, associations between the two, the increased risk for adverse outcomes, and the potential for restorative and preventive interventions, the accurate assessment of frailty in older adult psychiatric populations should be a priority. Of the 10 systematic reviews concerning frailty assessment published to date, 7, 24, [28] [29] [30] [31] [32] [33] [34] [35] none considered frailty assessment in the context of mental illness. Therefore, the aims of this review were to (1) establish if any existing multicomponent frailty assessment tools have been developed for or validated in older adult populations with a diagnosis of psychiatric disorder, and (2) establish any construct overlap between the assessment domains of existing multicomponent frailty assessment tools and the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) 36 diagnostic criteria for psychiatric disorders in older adults, exploring the potential impact of this on valid and reliable frailty assessment in this population.
METHODS

Search Strategy
The following databases were searched on February 15, 2017 : Medline (1946 , PsycINFO (1806-present), Embase (1947-present) , and the Cochrane Central Register of Controlled Trials. The search strategy used was frailty AND (older OR elder* OR geriatr*) AND (measure* OR assess*). The reference lists of 10 systematic reviews 7, 24, [28] [29] [30] [31] [32] [33] [34] [35] concerning frailty assessment identified through the search strategy just described were also searched manually.
Selection Criteria
Studies were selected for inclusion for review if they met the following criteria:
• All study participants were aged 60 years or older.
• The study described a multicomponent tool, defined as a tool that assesses two or more indicators of frailty, such as a frailty index.
• The study described a tool that was specifically developed to assess frailty.
• The main purpose of the study was the development and/or evaluation of the reliability and validity of a multicomponent tool to assess frailty.
• The study applied the original version of a multicomponent tool to assess frailty.
• The full content of the multicomponent tool was available (including all indicators of frailty, units of measurement, and scoring systems).
• The study reported quantitative data.
• The full peer-reviewed study text was available.
• Studies were available in English or were translated wherever possible.
Supplementary File 1 offers an expanded explanation of study selection criteria. The title and abstracts were screened, and potentially eligible studies were selected for inclusion by J.L.S. Studies were considered for inclusion regardless of their methodological quality.
Data Extraction and Analysis
Data were extracted regarding (1) study characteristics, (2) the population each tool was developed for and validated in, and (3) the content of each frailty assessment tool. Data for items 1 and 2 were extracted by two independent raters; data for item 3 were extracted by J.L.S.
Following data extraction, the assessment items of each frailty assessment tool were compared with the DSM-5 diagnostic criteria for the seven common psychiatric disorders in older adults: MDD, bipolar affective disorder (BAD), schizophrenia, GAD, social anxiety disorder (SAD), specific phobia (SP), and panic disorder (PD). 21, 36 An assessment of a definite construct overlap between the items of the frailty assessment tools and the DSM-5 diagnostic criteria was then completed. Definite construct overlap was defined as instances where the frailty assessment tool item and DSM-5 diagnostic criteria were conceptually the same (eg, "troubles with sleeping" and "insomnia or hypersomnia"). The exact units and process of measurement did not need to be the same, but they must have assessed the same theoretical construct. The potential for an individual to be assessed as frail or pre-frail based on mental health symptoms alone was also reviewed. Assessment of definite construct overlap was completed by two independent blinded raters (J.L.S., R.L.G., M.C.C., E.V.W., A.M.B., M.L., M.S., and A.R.). Any disagreements were resolved through discussion.
Assessment of Methodological Quality of Studies Included for Review
The COSMIN checklist is a standardized tool for evaluating the methodological quality of studies examining measurement properties of health-related instruments. 25, 37, 38 It assesses measurement properties across the following domains, awarding ratings of "excellent," "good," "fair," or "poor" quality, internal consistency, reliability, measurement error, content validity, structural validity, hypotheses testing, cross-cultural validity, criterion validity, and responsiveness. 25, 37, 38 A rating of excellent indicates the evidence provided for that measurement property is adequate. A rating of good indicates the evidence provided can be assumed to be adequate. A rating of fair indicates the evidence is questionable, and poor indicates the evidence provided is inadequate. The COSMIN checklist was applied to each study, and data were extracted by two independent blinded raters (J.L.S., R.L.G., M.C.C., A.M.B., E.V.W., M.S, and G.L.). Any disagreements were resolved through discussion.
Reporting
This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards 39 for reporting of systematic reviews.
RESULTS
Literature Search and Inclusion for Review
The literature search identified 5639 records in total following the removal of duplicates, from which 95 studies were included for review following assessment against selection criteria ( Figure 1 ). 3, 9, 26, 27, 
Study Characteristics
A full outline of study characteristics is provided in Supplementary Table 1 . Forty-eight multicomponent frailty assessment tools were examined across 95 studies. 3, 9, 26, 27, The most frequently observed study design was prospective cohort (32 of 95 studies). 3, 9, [40] [41] [42] [43] [44] [46] [47] [48] [49] 57, [68] [69] [70] 72, 73, 78, 80, 84, 87, 89, 92, 95, 97, 101, 105, 107, 114, 116, 129, 130 Of the 62 studies with follow-up data available, follow-up periods ranged from 1 month 51, 62, 71 to 348 months. 117 The total number of participants per study ranged from 14 119 to 931 541. 65 The overall total percentage of female participants, calculated by pooling the percentage female population from the 84 of 95 studies with data available, was 65.9%. The overall mean age of participants, calculated by pooling the mean ages from the 73 of 95 studies with data available, was 74.9 years. Participants were most commonly sampled from the Netherlands (29 of 95 studies). 
Methodological Quality of Studies Included for Review
The COSMIN checklist results are detailed in Supplementary Table 2 . In total, 7 of 95 studies had one aspect of methodological quality rated as excellent. 46, 54, 57, 82, 97, 109, 130 All ratings of excellent were in relation to content validity. A further 7 of 95 studies 65, 71, 86, 99, 101, 120, 121 had at least one aspect of methodological quality rated as good; hypothesis testing was the measurement property with the highest number of good ratings (4 of 7). Overall, 70 of 95 studies had at least one aspect of methodological quality rated as fair. Table 1 summarizes key findings in relation to the review aims. Table 2 provides an overview of construct overlap observed in relation to frailty assessment domains, and Supplementary Table 3 provides an overview of all construct overlap observed. Of the tools reviewed, only 7 of 48 had no definite construct overlap between frailty assessment tool items and DSM-5 diagnostic criteria for MDD, BAD, schizophrenia, GAD, SAD, SP, or PD: Brief Clinical Instrument to Classify Frailty, [40] [41] [42] the Clinical Frailty Scale (CFS), [46] [47] [48] [49] Frailty Predicts Death 1 Yea After Cardiac Surgery Test (FORECAST), 52, 53, 71 Frailty Index Based on Common Laboratory Tests (FI-LAB), 73 Korean Longitudinal Study of Health and Aging (KLoSHA) Frailty Index, 97 Palumbo Frailty Index, 100 and the 9-Item Frailty Measure. 130 In 29 of 48 tools, definite construct overlap was established between the nutritive domains of the frailty assessment tool (weight loss/reduced appetite) and DSM-5 diagnostic criteria for MDD and BAD 36 concerning weight loss and appetite changes. 57 and the Beck Depression Inventory II. 92 However, in most of these cases, items included from existing mental health tools were used to assess fatigue (6 of 12), 3, 9, 41, 56, 66, 77, 91, 102, 103, 106 rather than the presence of mental illness (5 of 12). 26, 42, 43, 61, [68] [69] [70] 92, 98 
DISCUSSION
To our knowledge, this is the first systematic review that has considered frailty assessment in the context of psychiatric disorders in older people. In summary, no tool identified in this review was developed for or validated in older adult populations with a psychiatric disorder. One tool tested in a psychogeriatric population, the Prognostic Risk Score, 105 was developed for and validated in a cohort of whom 80.8% had a dementia diagnosis. This identifies a gap in the current research.
Only seven tools were identified as having no definite construct overlap with DSM-5 diagnostic criteria: Brief Clinical Instrument to Classify Frailty [40] [41] [42] and CFS, [46] [47] [48] [49] screening instruments designed for use in general hospitals; FORECAST, 52, 53, 71 designed to assess frailty following cardiac surgery; FI-LAB, 73 based on common laboratory tests for use in long-term residential care facilities; KLoSHA Frailty Index, 97 developed for use with a communitydwelling elderly Korean population; Palumbo Frailty Index, 100 designed to assess frailty in multiple myeloma patients; and 9-Item Frailty Measure, 130 designed for use in routine geriatric practice.
However, as noted, none of these tools were developed for use in a mental health setting or with consideration for the complex interactions between frailty and psychiatric disorders. Significant construct overlap was identified between indicators of frailty as conceptualized in existing frailty assessment tools and DSM-5 diagnostic criteria for seven common psychiatric disorders. The diagnostic criteria for MDD (and thus the depression criteria for BAD) had the highest proportion of definite construct overlap with frailty assessment items (41 of 48 tools). The diagnostic criteria for GAD also had a high proportion of definite construct overlap (34 of 48 tools). The diagnostic criteria for SAD and SP had the lowest proportion of definite construct overlap observed (12 of 48 tools and 11 of 48 tools, respectively).
A total of 20 of 48 frailty assessment tools contained a psychological assessment domain, with 17 of 48 tools including the presence of depressed mood and/or anxiety as a frailty indicator. The frailty indicators and DSM-5 diagnostic criteria that had the most construct overlap concerned weight loss (29 of 48 tools) and fatigue (21 of 48). This construct overlap was further confounded by the inclusion of questions from existing psychiatric assessment tools to assess fatigue in 6 of 48 tools. For the tools for which there is a clear cutoff point to distinguish between individuals who are frail or robust, individuals could be classified as frail or pre-frail solely based on their mental health symptoms in half of them (16 of 31 tools). Thus this demonstrates significant potential for inaccurate assessment and recognition of frailty in psychiatric populations.
Specifically, significant construct overlap and confounding was observed for the frailty assessment tools with the most extensive reliability and validity testing 24 : FI-CGA 26 and TFI. 27 FI-CGA 26 items such as "problems with mood," "problems with motivation," and "changes in weight" were observed to have definite construct overlap with DSM-5 diagnostic criteria for MDD. On FI-CGA 26 it is possible to be assessed as frail based on psychiatric symptoms alone; the tool contains a psychological assessment domain and utilizes questions from the Geriatric Depression Scale 131 to assess mood, further increasing confounding. TFI 27 items such as "unexplained weight loss," "physical tiredness," and "feeling down" were observed to have definite construct overlap with DSM-5 diagnostic criteria for MDD. The TFI also includes a psychological assessment domain. Although it is not possible to be assessed as frail based purely on the definite construct overlap observed for TFI, the level of overlap is such that it is likely to confound frailty assessment in psychiatric populations. Definite construct overlap was also observed for tools based on the prominent cumulative deficit model 72 and the phenotype model, 9 increasing the risks of confounding when assessing frailty with these tools in psychiatric populations.
It is of note that there were many frailty assessment items for which a direct plausible association with DSM-5 diagnostic criteria was observed, but they did not meet the criteria for definite construct overlap. For example, tools such as the FI-LAB 73 contain a measure of serum albumin as part of a nutritive domain, with low levels indicating malnutrition. Although this cannot be classified as a definite construct overlap with the MDD diagnostic criterion "unintentional weight loss," there is a direct and plausible association. Tools such as the Brief Frailty Index 43 and Prognostic Risk Score Aim 2: To establish any construct overlap between the assessment domains of the existing multicomponent frailty assessment tools and the DSM-5 diagnostic criteria for psychiatric disorders in older adults.
• Assessment domains of 41 of 48 multicomponent frailty assessment tools significantly overlap with DSM-5 diagnostic criteria for psychiatric disorders.
• Indicators of frailty that significantly overlap with DSM-5 diagnostic criteria include weight loss/appetite changes (a diagnostic criterion in major depressive episode and bipolar affective disorder), fatigue (a diagnostic criterion in major depressive episode, bipolar affective disorder, and generalized anxiety disorder), reduced concentration/ processing skills (a diagnostic criterion in major depressive episode, bipolar affective disorder, and generalized anxiety disorder), slowness (a diagnostic criterion in major depressive episode and bipolar affective disorder), reduced activity levels (a diagnostic criterion in schizophrenia), and sleep disturbances (a diagnostic criterion in major depressive episode, bipolar affective disorder, and generalized anxiety disorder).
• Twenty frailty assessment tools contain a psychological assessment domain, explicitly measuring mental health symptoms.
• Seventeen frailty assessment tools include the presence of depressed mood and/or anxiety as a frailty indicator.
• Eleven frailty assessment tools include questions from existing psychiatric assessment tools to assess frailty indicators (eg, questions from the CES-D to establish fatigue).
• A classification of frailty/pre-frailty can be made solely on the basis of mental health symptoms in 16 of 31 tools in which there is a clear cutoff point to establish frailty.
• Most construct overlap was observed in relation to major depressive episode (and hence the depressive criteria for bipolar affective disorder) and generalized anxiety disorder. included "low body mass index" as an indicator of frailty, which again although highly associated with "unintentional weight loss," did not meet the criteria for definite overlap. Another example are tools such as the Palumbo Frailty Index 100 and the KLoSHA Frailty Index 97 that include a functional assessment of instrumental activities of daily living (IADLs). Although no definite construct overlap was identified, there is a plausible association between IADL assessment performance and the symptoms of fatigue and reduced interest in activities and concentration associated with MDD.
Research and Clinical Implications
No frailty assessment tool identified in this review was developed for use with, nor had its reliability or validity been tested in older adult psychiatric populations. Consequently, the evidence base for each frailty assessment tool lacks interpretability and generalizability in relation to psychiatric populations, significantly increasing the risk of invalid assessment and identification of frailty. Additionally, the risk of invalid frailty assessment in psychiatric populations is increased with the application of frailty assessment tools: (1) for which definite construct overlap was observed between assessment items and DSM-5 diagnostic criteria; (2) that include a psychological assessment domain; and (3) include items derived from psychiatric assessments.
Given the established high level of comorbidity of frailty with psychiatric disorders and evidenced associations between psychiatric disorders and frailty, inaccurate assessment of frailty in psychiatric populations holds substantial clinical risks. If frailty is not recognized and treated within this high-risk population, the potential for adverse outcomes including worsening of psychiatric symptoms and delayed psychiatric remission increases. 12, 19, 20 Similarly, if an individual is inaccurately assessed as frail or pre-frail based on psychiatric symptoms alone, this could inappropriately or unnecessarily inform treatment planning and provisions. At a wider level, the presence of frailty and psychiatric disorders individually represents increased risks of adverse outcomes including functional decline, institutionalization, and mortality. [1] [2] [3] [4] [5] 21 Accurate assessment and thus treatment of frailty in the context of psychiatric disorder is essential to minimize the risks of such adverse outcomes and associated increased healthcare service utilization.
In research terms, the implications of inaccurately assessing frailty are also substantial including an increased likelihood of the interpretation and reporting of flawed results. There exists the potential to identify a research population as frail based on their mental health symptoms alone, thus limiting the potential to identify a "true" frail psychiatric population. Considering the established research priorities specific to this population, including the need to develop specialist treatments and preventive interventions, the impact of this is considerable.
Further research is necessary to establish a reliable and valid tool to assess frailty accurately in older adults with a diagnosis of psychiatric disorder. Some level of construct overlap and confounding between the indicators of frailty and of psychiatric disorder is inevitable. For example, sarcopenia is widely considered a fundamental component of the frailty syndrome, and unintentional weight loss is an established symptom of MDD, both of which are highly related concepts. However, it may be possible to minimize this construct overlap by considering the way that indicators are conceptualized and measured, for example, by defining and measuring the frailty indicator "slowness" in a way that minimizes construct overlap with psychomotor retardation. Future research is required to establish this.
Limitations of the Review
This review has several limitations. The search strategy was completed in February 2017; therefore any potentially relevant studies published after this date were not considered for review. Studies were assessed against inclusion criteria by the lead author (J.L.S.) only, increasing the risk of selection bias. This was minimized by strict adhesion to the search strategy and following the PRISMA standards for reporting in systematic reviews. Data extraction concerning the content of frailty assessment tools was also completed by J.L.S. only; however, all analysis including assessments of construct overlap were completed by two independent raters. Studies concerning tools that were not explicitly developed to assess frailty were excluded, limiting the scope of this review but deemed appropriate given the multifaceted nature of the frailty presentation.
The COSMIN checklist applied also has a number of limitations (see previous review for discussion of these limitations). 24 However, COSMIN is a standardized tool for evaluating the methodological quality of studies examining measurement properties of health-related instruments, so it was deemed appropriate. In establishing construct overlap between frailty assessment tool items and psychiatric indicators, the use of a different set of diagnostic criteria for mental illnesses such as the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) 132 may have produced variation in the areas of construct overlap identified. Due to the large volume of tools reviewed, it was not possible to apply two separate sets of diagnostic criteria. Because the DSM-5 provides in-depth descriptions of diagnostic criteria and is widely used, it was considered appropriate. Finally, although most of the construct overlap observed was due to actual construct overlap, a small amount could be attributed to ambiguous wording of the frailty assessment tool items. For example, the term "problems with" allows for a large range of symptoms to be scored under one item.
In conclusion, to date, no multicomponent frailty assessment tool has been developed for or validated in older adult populations with psychiatric disorders. This review has provided an in-depth analysis of construct overlap and confounding between the indicators of frailty as conceptualized in existing frailty assessment tools and DSM-5 diagnostic criteria for seven common psychiatric disorders. In designing a tool for use with older adults with the diagnosis of a psychiatric disorder, special consideration should be given, where possible, to minimize the construct overlap identified in this review. Further research is necessary to establish a reliable and valid tool to assess frailty accurately in this specific population.
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